Form 8-K - Current report:
SEC Accession No. 0001641172-25-005036
Filing Date
2025-04-16
Accepted
2025-04-16 16:05:28
Documents
17
Period of Report
2025-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54534
2 ex10-1.htm EX-10.1 72528
3 ex99-1.htm EX-99.1 14810
  Complete submission text file 0001641172-25-005036.txt   386974

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdt-20250412.xsd EX-101.SCH 3839
5 XBRL DEFINITION FILE cdt-20250412_def.xml EX-101.DEF 30119
6 XBRL LABEL FILE cdt-20250412_lab.xml EX-101.LAB 36866
7 XBRL PRESENTATION FILE cdt-20250412_pre.xml EX-101.PRE 27142
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6013
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25842755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)